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Available online 19 March 2014AbstractThe purpose of this study was to determine the effects of 12 weeks of high-intensity interval training (HIIT) on visfatin and insulin resistance
(IR) in overweight adult men during a weight-loss program. Eighteen overweight men (age ¼ 31.8  9.2 years; body mass
index ¼ 28.6  1.4 kg/m2) were randomly recruited into one of the two groups, namely, HIIT (3 days/week, 20 minutes/day; 85e95% peak
oxygen uptake) and diet-induced weight-loss combined (DHIIT; n ¼ 10) and diet-induced weight loss only (DIO; n ¼ 8). The DHIIT and DIO
groups undertook a 12-week weight-loss intervention using a moderate isocaloric energy-deficit diet. Both DHIIT and DIO groups demonstrated
a significant reduction in body weight (p < 0.01). Total fat mass (p < 0.05) and lean body mass (p < 0.05) were decreased in the DIO group with
no significant changes in abdominal fat mass, plasma insulin concentration, homeostasis model assessment-estimated IR (HOMA-IR), blood
glucose level, and plasma visfatin. In the DHIIT group, total fat mass (p < 0.01), abdominal fat mass (p < 0.05), plasma insulin concentration
(p < 0.05), plasma visfatin (p < 0.01), and HOMA-IR (p < 0.05) were reduced and lean body mass remained unchanged. In conclusion, adding
a low-volume 20-minute HIIT (three times/week) to an energy-deficit diet not only can improve the efficiency of weight-loss program in the
reduction of body fat, plasma visfatin levels, and HOMA-IR, but also has a reservation effect on lean body mass.
Copyright  2014, The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Visfatin is a new obesity-related adipokine that is isolated
from the visceral adipose tissue.1 However, some subsequent
studies were unable to find differences in visfatin messenger
RNA expression between visceral and subcutaneous adipose
tissues in humans.2,3 There are conflicting results regarding
the changes in plasma visfatin levels during the development
of obesity, with some reporting an increase1,2 and some
reporting a decrease in levels.4 It is primarily supposed that* Corresponding author. Department of Exercise Physiology, Faculty of
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access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-ndvisfatin exerts an insulin-mimetic effect by binding to and
stimulating the insulin receptor as well as by lowering plasma
glucose levels.1 Nevertheless, several studies have revealed a
negative association between plasma visfatin level and insulin
sensitivity.3,5 According to Haider et al6 hyperglycemia
enhanced circulating visfatin levels in humans, suggesting that
visfatin release may be associated with plasma glucose con-
centration. Finally, some studies suggest that visfatin may be
involved in a mechanism that induces insulin secretion in
isolated pancreatic islets.7
Hypocaloric diet and exercise are the most common strate-
gies for weight-loss programs and controlling obesity, sug-
gesting improvements in insulin sensitivity and changes in
plasma visfatin concentration. Several studies advocate the
decreasing effect of gastric surgery or hypocaloric diet oncise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. This is an open
/4.0/).
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(e.g., Manco et al8 Haider et al9 De Luis et al10); by contrast, a
previous study reported that weight loss after gastroplastic
surgery is associated with an increase in circulating concen-
trations of visfatin, which correlated with the decrease in insulin
resistance (IR).11 De Luis et al12 in a study conducted on
morbidly obese patients, found out that weight reduction after a
hypocaloric diet is not accompanied by a change in circulating
visfatin levels; however, fat mass, fat-free mass, serum glucose,
insulin, and homeostasis model assessment (HOMA)
decreased. Agueda et al’s13 findings demonstrated that lean
mass changes due to weight loss might be more effective than
fat mass changes in serum visfatin concentration. Only limited
studies that reported the effects of exercise on circulating vis-
fatin are available. Several studies suggest that exercise training
with weight loss induces reduction of plasma visfatin concen-
tration that is accompanied by benefits to body composition,
metabolic syndrome factors, and IR.14e16 Nevertheless, Seo
et al17 did not find any changes in plasma visfatin levels after
combined exercise training in healthy women.
Most recent studies have examined the effects of aerobic
exercise training or a combination of resistance training and
aerobic exercise training on plasma visfatin level, IR, and body
composition in overweight or obese individuals.14e17
Increasing evidence suggests that high-intensity interval
training (HIIT) through positive changes in hormone secretion
and enzymatic adaptation can effectively improve abdominal
and subcutaneous fat loss, IR, fat oxidation, appetite regulation,
and aerobic capacity.18e20 In addition, HIIT involves notice-
ably lesser training volume, making it a time-efficient approach
with increased health benefits compared with aerobic exercise
training.21,22 Consequently, it is possible that visfatin would
respond to low-volume HIIT. To the best of our knowledge,
there is no study that has investigated the effects of HIIT on
circulating visfatin in overweight and obese men during the
weight-loss program. Thus, the purpose of our study is to
define the effects of 12 weeks of HIIT on visfatin and IR in
overweight and obese adult men during a weight-loss program.
MethodsParticipantsA total of 18 healthy men (age ¼ 31.8  9.2 years) were
recruited for this study. The participants had been registered
for a weight-loss program by Iranian Health Clinic of Isfahan,
Iran. All participants underwent a complete medical exami-
nation, filled up the physical activity questionnaire, and had
their weight and height measured before inclusion. We omitted
the participants who were smokers, had any severe illness
(e.g., diabetes, cardiovascular disease), or were taking medi-
cation that could affect laboratory test results. All participants
were overweight [body mass index (BMI) ¼ 28.6  1.4 kg/
m2] with a sedentary lifestyle (less than 20-minute exercise
two times/week). Participants were randomly assigned to
either an HIIT and diet-induced weight-loss combined (i.e.,
DHIIT; n ¼ 10) or diet-induced weight loss only (DIO; n ¼ 8)group. For each participant, both pretests and post-tests were
executed at the same time of the day. There was no significant
difference between the two groups with respect to age, weight,
height, or BMI. The Sport Science Department of the Central
Branch of Tehran Azad University approved the study proto-
col. The participants signed an informed consent document
before participation.Training programEach high-intensity interval exercise session involved
repeated 60-second running at a high intensity (85e95% heart
rate reserve), which was alternated by 60-second running at a
low intensity (55e60% heart rate reserve) for recovery.23
Participants finished six high-intensity intervals during the
1st week, eight intervals during the 2nd week, 10 intervals
during the 3rde8th weeks, and 12 intervals on the final 4
weeks. A 5-minute low-intensity running was performed as a
warm up in the beginning and 3-minute recovery period was
provided at the end of each training session. Therefore, each
main exercise lasted between 20 and 24 minutes approxi-
mately. The total training program was carried out for 12
weeks, three times/week (Saturday, Monday, and Wednesday)
under the supervision of an exercise physiologist. To assess the
peak oxygen uptake (VO2peak), all participants performed an
incremental graded exercise test to exhaustion (Balk protocol)
on a programmable treadmill, while using an online gas
analyzer system (PowerCube, GANSHORN, Germany). To
indicate the attainment of VO2peak, the following criteria were
fulfilled: oxygen uptake plateaus with a further increase in
workload, a respiratory exchange ratio (RER) more than 1.15,
ratings of perceived exertion (RPE) more than 17, volitional
exhaustion, and an heart rate (HR) greater than or equal to
age-predicted maximum. The energy expenditure of each ex-
ercise session totaled to about 300e400 kcal that was calcu-
lated by the VO2 consumption corresponding of heart rate
during exercise.24 All participants used a heart rate monitor
device during every exercise session to control the targeted
heart rate.Dietary interventionDaily caloric requirements were predicted using body
weight, height, age, gender, and physical activity level. The
weight-loss diet consisted of an energy-deficit diet by
2000e3000 kcal/week in the DHIIT group and
3000e4000 kcal/week in the DIO group. The dietary protocol
was a balanced healthy diet that included the six categories of
foods. The balanced diet comprised 50e55% carbohydrate,
20e25% protein, and 25e30% fat. All participants visited the
nutritionist once a week to assess their dietary intake, obtain
dietary recommendations, and calculating reduction in weight.Body compositionBody composition was measured using a dual-energy X-ray
absorptiometry (DEXA) scanning device (Discovery-A,
Table 1
Baseline values.
DHIIT (n ¼ 10) DIO (n ¼ 8) p
Age (y) 31.4  10.2 32.5  9.3 0.87
Height (cm) 176.0  7.5 182.2  4.9 0.19
Body weight (kg) 90.6  8.9 92.7  7.0 0.70
BMI (kg/m2) 29.2  1.6 28.1  0.7 0.19
Fat mass (kg) 34.9  3.6 34.8  5.4 0.99
Abdominal fat mass (kg) 4.7  0.6 4.5  1.0 0.71
Lean body mass (kg) 53.3  5.6 55.5  0.9 0.49
Glucose (mmol/L) 4.7  0.3 4.6  0.5 0.72
Insulin (mU/mL) 8.0  1.8 11.0  4.1 0.19
HOMA-IR 1.6  0.3 2.2  0.8 0.24
Visfatin (ng/mL) 16.2  3.5 19.2  2.7 0.20
22 H. Matinhomaee et al. / Journal of Exercise Science & Fitness 12 (2014) 20e25Hologic Inc., Holt, Michigan, USA). To avoid deviations in
hydration grade, the scans were obtained after 8e9 hours of
fasting. Daily calibration values were obtained to ensure that
the devices provided consistent results. We standardized
participant location for the scans and followed the manufac-
turer’s recommendations. To assess abdominal adiposity, one
trained assessor intercepted a section between T12 and L4
from the whole-body DEXA scans. Body weight, without
shoes and excess clothing, was determined in kilogram
(measuring accuracy: 0.1 kg), and height was measured with
bare feet in standing position (measuring accuracy: 1.0 cm).
The BMI was calculated as body mass (kg) divided by the
square of height (m2).Data are presented as mean  standard deviation.
BMI ¼ body mass index; DHIIT ¼ diet and high-intensity interval training
combined; DIO ¼ diet-induced only; HOMA-IR ¼ homeostasis modelBlood analyses
assessment-estimated insulin resistance.Blood samples were taken in the morning after an 8e9-
hour overnight fasting. Blood samples were centrifuged for
10 minutes at 4C and plasma samples were stored at 80C
for subsequent analyses. Blood samples were collected 3 days
before the start of the training program and 48 hours after the
last exercise session. Plasma visfatin levels were measured
using a specific enzyme-linked immunosorbent assay (ELISA)
kit (Phoenix Peptides, Karlsruhe, Germany). The intra-assay
coefficient of variation (CV) was approximately 5%. Human
insulin ELISA kit was used to measure the plasma insulin
concentration (DiaMetra, Foligno, Perugia, Italy) with an
intra-assay CV less than 4.5%. The glucose oxidase technique
was used to measure blood glucose levels. The IR was
calculated by the HOMA for all participants. The HOMA-IR
was calculated using the formula [fasting glucose (mmol/
L)  fasting insulin (mU/mL)/22.5].25 A single assessor took
all samples in duplicate for each factor.Statistical analysesDescriptive data were expressed as means  standard de-
viations. Differences between the DIO and DHIIT group
characteristics were verified by independent Student t test at
baseline. Changes in variables from pretest to post-test were
detected by paired Student t test. The two-way repeated
measures analysis of variance method was applied to measure
groupetime interactions (group  time; 2  2). Statistical
significance was set at p < 0.05 and SPSS 15.0 was used for
all analyses (SPSS Inc., Chicago, IL, USA).
Results
Table 1 shows all characteristics at baseline. There were no
significant differences between the two groups on any
parameter before intervention (Table 1).
Body weight reduction after the 12-week intervention in the
DIO group was 5.4% (5.0  1.6 kg; p < 0.01) and in the
DHIIT group it was 8% (7.2  2.6 kg; p < 0.01). In the DIO
group, significant decreases were observed in fat mass
(p < 0.05) and lean body mass (p < 0.05). However, there was
no significant change in blood glucose level, abdominal fatmass, plasma insulin concentration, HOMA-IR, and plasma
visfatin. In the DHIIT group, we found significant reduction in
fat mass (p < 0.01), abdominal fat mass (p < 0.05), plasma
insulin concentration (p < 0.05), plasma visfatin (p < 0.01),
and HOMA-IR (p < 0.05), while no significant variation in
total lean mass and blood glucose level was observed in this
group (Table 2).
A significant groupetime interaction was observed for
some parameters. In comparison with the DIO group, the
DHIIT group had greater decreases in total fat mass (p < 0.05)
and abdominal fat mass (p < 0.05). However, there was no
significant groupetime interaction in body weight, plasma
insulin concentration, blood glucose level, HOMA-IR, plasma
visfatin levels, and total lean body mass (Table 2).
Discussion
The results of this study indicate that both DHIIT and DIO
significantly decreased body weight, but only DHIIT caused a
significant reduction in plasma visfatin level, abdominal fat
mass, fasting insulin level, and HOMA-IR. Although both
weight-loss programs decreased total fat mass, the reduction
was significantly more in DHIIT than in DIO. There was a
significant loss of total lean mass only in the DIO group.
Both DHIIT and DIO protocols decreased body weight by
8% and 5.4%, respectively. Body weight reduction was greater
(but not significant) in the DHIIT compared with the DIO
group; however, the total energy deficit was the same in the
both groups. The difference in weight loss may be explained
by the fact that high-intensity exercise increases metabolic rate
and decreases energy intake in the postexercise state.26,27
Interestingly, weight loss in the DHIIT group is accompa-
nied by a major reduction in fat mass and almost no change in
lean mass, whereas in the DIO group, considerable fraction
(40%) of weight loss was due to lean mass reduction. These
findings are in agreement with those reported by Tremblay
et al21 and Trapp et al22 Elevated catecholamine levels in
response to HIIT can explain major reduction of fat mass in
the DHIIT group as catecholamine would stimulate lipolysis
Table 2
Preintervention and postintervention values.
DHIIT DIO (G  T )
Pre Post p Pre Post p p
Age (y) 31.4  10.2 e e 32.5  9.3 e e e
Height (cm) 176.0  7.5 e e 182.2  4.9 e e e
Body weight (kg) 90.6  8.9 83.4  9.7 0.004* 92.7  7.0 87.7  7.3 0.009* 0.196
BMI (kg/m2) 29.2  1.6 26.8  2.1 0.004* 28.1  0.7 26.3  0.7 0.011** 0.152
Fat mass (kg) 34.9  3.6 28.6  4.6 0.001* 34.8  5.4 32.2  6.8 0.037** 0.017***
Abdominal fat mass (kg) 4.7  0.6 3.6  1.1 0.015** 4.5  1.0 4.2  1.1 0.115 0.046***
Lean body mass (kg) 53.3  5.6 52.3  5.8 0.299 55.5  0.9 53.3  0.2 0.019** 0.286
Glucose (mmol/L) 4.7  0.3 4.4  0.3 0.116 4.6  0.5 4.6  0.3 0.774 0.163
Insulin (mU/mL) 8.0  1.8 5.8  3.1 0.049** 11.0  4.1 9.7  5.3 0.141 0.401
HOMA-IR 1.6  0.3 1.1  0.6 0.034** 2.2  0.8 2.0  0.9 0.221 0.317
Visfatin (ng/mL) 16.2  3.5 13.7  4.1 0.008* 19.2  2.7 18.1  1.3 0.243 0.154
Data are presented as mean  standard deviation.
*Significant change from pre to post in HIIT and DIO groups (p < 0.01).
**Significant change from pre to post in HIIT and DIO groups (p < 0.05).
***Significant group and time interaction (p < 0.05).
BMI ¼ body mass index; DHIIT ¼ diet and high-intensity interval training combined; DIO ¼ diet-induced only; HOMA-IR ¼ homeostasis model assessment-
estimated insulin resistance; (G  T ) ¼ group and time interaction.
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fat stores.28,29 The anabolic effects of growth hormone (GH)
have been demonstrated extensively.30 Thus, a marked eleva-
tion in plasma GH after a high-intensity exercise bout that
continues to be high even after 1 hour following an exer-
cise31,32 could be an explanation for lean mass retention in the
DHIIT group. Overall, these data show that addition of HIIT
(3 sessions/week) to a weight-loss program results in a sig-
nificant improvement in weight loss, fat mass reduction, and
lean mass maintenance.
An important finding of this study was that plasma visfatin
did not significantly change in the DIO group. Changeless
visfatin levels seen in this group is consistent with that re-
ported by De Luis et al12 who reported that a moderate
hypocaloric diet in morbidly obese individuals, despite a sig-
nificant reduction in weight (4.4%), fat mass, fat-free mass,
and HOMA was not accompanied by a change in circulating
visfatin. However, our findings do not support the results of De
Luis and co-workers’ study,10 in that they found that weight
loss after 12 weeks of hypocaloric diet is related to significant
decreases in plasma visfatin level in obese individuals. One
possible explanation for this discrepancy is that body weight
reduction in the DIO group of this study is not sufficient for a
significant reduction in circulating visfatin.
This is the first study to survey the effects of HIIT program
on plasma visfatin concentration in sedentary, adult, over-
weight, or obese men during a weight-loss program. Signifi-
cant reduction in the plasma visfatin level in the DHIIT group
was the main finding of this study. This finding has also been
observed in previous studies that used endurance or combined
exercise training (e.g., Choi et al14 Seo et al15 Haus et al16).
Seo et al15 showed that 12 weeks of combined (aerobic and
resistance) exercise training lowered plasma visfatin concen-
tration in obese women that was accompanied by positive
changes in body composition. Choi et al14 have also executed
a combined training program on Korean healthy women that
included aerobic training (45 minutes/session) and strengthtraining (20 minutes/session) five times/week for 3 months.
They found significant decreases in visfatin levels and body
weight of participants. Besides, Haus et al16 found that in-
cremental aerobic exercise training also resulted in significant
reduction in plasma visfatin in addition to weight loss and
body composition changes. However, Seo et al17 did not find
any significant changes in visfatin level despite significant
reduction in body weight and fat percentage. These findings
show that low-volume HIIT (60 minute/week) has the same
effects as high volume combined or aerobic exercise training
(180e300 minute/week) on visfatin levels.
The present study revealed that DHIIT, but not DIO,
significantly decreased plasma visfatin levels. This difference
may be due to increased reduction of total and abdominal fat
mass in the DHIIT group. It is based on the suggestion that
visceral adipose tissue is the main site of visfatin produc-
tion.1 Moreover, Haus et al16 have demonstrated a strong
correlation between alteration in visfatin levels and visceral
adipose tissue. Further, some studies have shown a signifi-
cant reduction in body fat mass along with reduction in
plasma visfatin level.8,9 The other possible explanation for
this difference is a significant reduction of lean mass in the
DIO group. This has been supported by the results of Agueda
et al13 who demonstrated that changes in lean mass due to
weight loss might be more effective than fat mass changes in
serum visfatin concentration. They found a significant
negative association between the change in plasma visfatin
and the change in lean mass, without any relationship be-
tween fat mass and visfatin changes after energy-restricted
diet intervention.
Finally, we found that fasting plasma insulin concentration
and HOMA-IR were significantly reduced in the DHIIT group,
whereas there was no significant change in the DIO group. The
high effectiveness of HIIT on HOMA-IR reduction has been
observed in previous studies.22 The significant decrease of
HOMA-IR in the DHIIT group can be due to the reduction in
abdominal fat mass. This is in line with significant association
24 H. Matinhomaee et al. / Journal of Exercise Science & Fitness 12 (2014) 20e25between abdominal fat loss and decreases in IR after weight-
loss program.33
Although the metabolic role of visfatin is not clearly un-
derstood, simultaneous reduction of insulin, plasma visfatin
levels, and HOMA-IR in the DHIIT group suggests a link be-
tween visfatin and insulin sensitivity. A possible explanation for
the concurrent changes in plasma visfatin and insulin concen-
tration is provided Revollo et al7 They reported a decreased
sensitivity of beta cells to glucose by reduced plasma visfatin
levels. Thus, the reduction of blood visfatin concentration may
lead to decreased insulin secretion. The results of this study
confirm the hypothesis byHaus et al16 that exercise trainingmay
adjust insulin response to glucose by modifying the plasma
visfatin level. However, this is in contrast with the findings of
Choi et al14 who reported that 12 weeks of combined exercise
training significantly reduced visfatin levels, whereas the IR
remained unchanged. Overall, further studies are needed to
clarify the role of visfatin in metabolic regulation.
The relatively small number of participants is the main
limitation of this study. Although the small size did not
damage the clear differences in variables within or between
groups due to intervention, our results cannot be generalized to
other groups. The major advantages in this study were the
directly supervised exercise session and carefully controlled
diet of all participants. We recommend further studies using a
larger sample. In addition, similar studies conducted on
women may provide different results.
In conclusion, this study demonstrates that both DHIIT and
DIO reduce weight and body fat in overweight men. However,
only DHIIT results in a significant reduction in plasma vis-
fatin, abdominal fat mass, and IR as well as conservation of
lean body mass. In addition, DHIIT shows a greater reduction
in body weight and total body fat. These observations
demonstrate that adding a low-volume 20-minute HIIT (three
times/week) to an energy-deficit diet can improve the health
benefits of a weight-loss program.
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